Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model.

Cell Mol Gastroenterol Hepatol 2019 9;8(2):193-195. Epub 2019 May 9.

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcmgh.2019.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661391PMC
July 2020
8 Reads

Publication Analysis

Top Keywords

ameliorates colitis
4
humanized mouse
4
colitis preclinical
4
preclinical humanized
4
interleukin-2 ameliorates
4
low-dose interleukin-2
4
mouse model
4
mouse
1
model
1
preclinical
1
ameliorates
1
colitis
1
low-dose
1
humanized
1

Similar Publications